Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722107 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Strategic Perspectives: Pancreatic Cancer - Gemcitabine Combination Therapy is the Future
Datamonitor, Nov 2002, Pages: 125

  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  
Enquire before Buying
To contact our Customer Service Team complete all fields below and click on "Send". We aim to respond to all enquiries on the same business day.

 * Required Information
Your Question
  Enquiry Subject *

Your Question *
Your Contact Details
  Your Title *
                  
First Name *       Last Name *

 
  
 

Email Address *

 

Country *
 
Phone Number *
 
You will be emailed a special link to our Customer Service Enquiry System to track your reply. To make sure that Research and Markets customer support emails reach your inbox and are not filtered into your "junk" or "bulk" folder, please whitelist our email domain which is @researchandmarkets.net
 



Customers who bought this item also bought

Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged

Niche Cancers 2001: Pancreatic Cancer

Stakeholder Opinions: Pancreatic Cancer - Gemzar Dominance will Continue among High Levels of Persistent Unmet Needs

Cancer Pancreatic Cancer

Drugs of Tomorrow: Cancer Overview

Strategic Perspectives 2002: Colorectal Cancer Cost Analysis

Br Malls Participacoes Sa

Br. Holdings Corporation

Drugs of Tommorow 2002: Breast Cancer

Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride

Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies

Strategic Perspectives 2002: Cancer Adjunct Therapies
Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds